Evaluating muscle involvement in systemic sclerosis
Evaluation of Muscle Involvement in Systemic Sclerosis
Central Hospital, Nancy, France · NCT06051773
This study is trying to see how often and in what ways muscles are affected in people with systemic sclerosis to better understand their condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Central Hospital, Nancy, France (other) |
| Locations | 1 site (Nancy) |
| Trial ID | NCT06051773 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the prevalence and characteristics of muscle involvement in patients with systemic sclerosis (SSc). It will evaluate muscle damage through various methods, including creatinine kinase levels, electromyography abnormalities, muscle MRI hyperintensities, and muscle biopsy inflammation. The study seeks to identify differences between SSc patients with and without muscle involvement and to categorize those with muscle involvement into homogeneous groups. The findings could enhance understanding of muscle-related manifestations in SSc and their association with other clinical features.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with systemic sclerosis based on the 2013 ACR/EULAR classification criteria.
Not a fit: Patients without a diagnosis of systemic sclerosis will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and management of muscle involvement in systemic sclerosis patients.
How similar studies have performed: While muscle involvement in systemic sclerosis has been noted in literature, this study aims to provide a more structured evaluation, making it a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with systemic sclerosis according to 2013 ACR/EULAR classification criteria
Where this trial is running
Nancy
- Paul Decker — Nancy, France (RECRUITING)
Study contacts
- Study coordinator: Paul Decker, MD
- Email: p.decker@chru-nancy.fr
- Phone: +33383157240
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Systemic Sclerosis